跳至主要内容
临床试验/CTRI/2021/05/033544
CTRI/2021/05/033544招募中2 期

A Prospective, randomized, open-labelled, active comparator trial of Indomethacin versus Paracetamol among hospitalized patients with confirmed Covid-19.

IIT Madras0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
IIT Madras

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age between 20 to 90 years
  • RT â?? PCR Positive
  • Hospitalised patients
  • The case criteria for the study â?? Renal Function Test and Liver Functional Test should be normal at the screening; Oxygen saturation should be 95% or more

排除标准

  • Hypersensitivity/Allergy to Drug
  • Recent Heart attack
  • Severe Asthma
  • Acute Kidney Injury.
  • Patients on immune suppressants
  • To Exclude pregnant and lactating mothers
  • Specify NSAID/Indomethacin allergy

研究者

发起方
IIT Madras

相似试验

尚未招募
2 期
Efficacy of Indomethacin along with standard care of treatment versus standard care of treatment in hospitalized Severe Covid -19 patients
CTRI/2021/08/035567IIT Madras
已完成
4 期
post-marketing study to evaluate the efficacy and safety of (silodosin) vs Tamsulosin in Indian male patients with lower urinary tract symptoms associated with benign prostatic hyperplasia.
CTRI/2019/12/022231Sun Pharma Industries Ltd246
尚未招募
3 期
Study on effect of calcium supplementation on pregnant wome
CTRI/2022/12/047860G.C Chemie Pharmie Limited
进行中(未招募)
不适用
A prospective, randomized, open-label, active-controlled study in adult subjects with acute bacterial sinusitis comparing the clinical efficacy of telithromycin (KETEK®) 800 mg once a day for 5 days versus amoxicillin-clavulanic acid (AUGMENTIN®) 875/125 mg twice a day for 10 days.acute bacterial sinusitis (ABS)MedDRA version: 7.0Level: LLTClassification code 10000858
EUCTR2004-001460-42-DEAventis Intercontinental - Sanofi-aventis298
进行中(未招募)
不适用
''A prospective, randomized, open label, active comparator, multicenter, national trial to compare the efficacy and safety of sequential IV/PO moxifloxacin 400 mg once daily versus IV amoxicillin/clavulanate 2,0/0,2 g every 8 hours followed by oral amoxicillin/clavulanate 875/125 mg every 8 hours in the treatment of adult subjects with complicated skin and skin structure infections'' - MERAKcSSSIsMedDRA version: 9.1Level: LLTClassification code 10040872Term: Skin infection
EUCTR2007-001491-36-ITBAYER
Comparison of efficacy of Indomethacin vs... | 临床试验